Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene correction by RNA-DNA oligonucleotides.

V Alexeev1, K Yoon

  • 1Department of Dermatology and Cutaneous Biology, Jefferson Institute of Molecular Medicine, Jefferson Medical College, Philadelphia, PA 19107, USA.

Pigment Cell Research
|June 7, 2000
PubMed
Summary

A novel RNA-DNA oligonucleotide (RDO) corrects single-base mutations in mammalian cells. This gene correction technology shows promise for treating genetic skin diseases by permanently altering target genes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

White matter tracts that overlap with the thalamus and the putamen are protected against multiple sclerosis pathology.

Multiple sclerosis and related disorders·2021
Same author

Differential gene expression in laboratory strains of human head and body lice when challenged with Bartonella quintana, a pathogenic bacterium.

Insect molecular biology·2014
Same author

PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling.

Oncogene·2013
Same author

Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine.

Gene therapy·2013
Same author

CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110).

Oncogene·2012
Same author

Assessment of follow-up sonography and clinical improvement among infants with congenital muscular torticollis.

AJNR. American journal of neuroradiology·2012

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Single-base mutations are a common cause of genetic disorders.
  • Current gene correction technologies face challenges in efficiency and applicability.

Purpose of the Study:

  • To develop and evaluate a novel RNA-DNA oligonucleotide (RDO) for precise gene correction.
  • To assess the efficacy of RDOs in correcting point mutations in mammalian cells, both in vitro and in vivo.

Main Methods:

  • Designed a unique oligonucleotide with RNA and DNA residues and hairpin caps to resist cellular degradation.
  • Utilized RNA-DNA hybrids for enhanced recombination.
  • Tested RDOs for correcting a tyrosinase gene mutation in mouse melanocytes and in live mice.

Related Experiment Videos

Main Results:

  • Achieved permanent correction of the tyrosinase gene mutation in mouse melanocytes, confirmed at genomic, protein, and phenotypic levels.
  • Demonstrated in vivo gene correction in albino mice, evidenced by hair pigmentation and DOPA staining.
  • Observed variable correction frequencies across cell types, suggesting the role of cellular repair mechanisms.

Conclusions:

  • RNA-DNA oligonucleotides (RDOs) offer a promising therapeutic strategy for genetic skin diseases.
  • Further research is needed to understand the mechanism of RDO-mediated gene conversion and optimize their design for improved efficiency and broader application.